Brookstone Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Sell |
33,217
-373
| -1% | -$14.3K | 0.02% | 509 |
|
|
2025
Q1 | $1.3M | Buy |
33,590
+1,889
| +6% | +$73.2K | 0.02% | 493 |
|
|
2024
Q4 | $1.07M | Buy |
31,701
+5,244
| +20% | +$177K | 0.02% | 512 |
|
|
2024
Q3 | $1.08M | Buy |
26,457
+718
| +3% | +$29.4K | 0.02% | 505 |
|
|
2024
Q2 | $1.03M | Sell |
25,739
-911
| -3% | -$36.3K | 0.02% | 496 |
|
|
2024
Q1 | $1.14M | Sell |
26,650
-1,027
| -4% | -$44K | 0.02% | 459 |
|
|
2023
Q4 | $1.03M | Sell |
27,677
-566
| -2% | -$21K | 0.02% | 451 |
|
|
2023
Q3 | $1,000K | Buy |
28,243
+2,570
| +10% | +$91K | 0.02% | 422 |
|
|
2023
Q2 | $868K | Sell |
25,673
-220
| -0.8% | -$7.44K | 0.02% | 462 |
|
|
2023
Q1 | $968K | Buy |
25,893
+5,373
| +26% | +$201K | 0.02% | 461 |
|
|
2022
Q4 | $717K | Buy |
20,520
+1,624
| +9% | +$56.7K | 0.01% | 502 |
|
|
2022
Q3 | $574K | Sell |
18,896
-20,866
| -52% | -$634K | 0.01% | 538 |
|
|
2022
Q2 | $2.1M | Buy |
39,762
+23,697
| +148% | +$1.25M | 0.05% | 282 |
|
|
2022
Q1 | $933K | Sell |
16,065
-20,039
| -56% | -$1.16M | 0.02% | 433 |
|
|
2021
Q4 | $1.98M | Buy |
36,104
+291
| +0.8% | +$16K | 0.03% | 269 |
|
|
2021
Q3 | $1.74M | Buy |
35,813
+415
| +1% | +$20.1K | 0.03% | 283 |
|
|
2021
Q2 | $1.79M | Buy |
35,398
+21,724
| +159% | +$1.1M | 0.03% | 276 |
|
|
2021
Q1 | $610K | Buy |
13,674
+6,224
| +84% | +$278K | 0.02% | 326 |
|
|
2020
Q4 | $343K | Buy |
7,450
+1,011
| +16% | +$46.5K | 0.01% | 363 |
|
|
2020
Q3 | $303K | Buy |
+6,439
| New | +$303K | 0.01% | 333 |
|
|
2015
Q4 | – | Sell |
-124
| Closed | -$6K | – | 449 |
|
|
2015
Q3 | $6K | Sell |
124
-1,345
| -92% | -$65.1K | ﹤0.01% | 1336 |
|
|
2015
Q2 | $76K | Buy |
+1,469
| New | +$76K | 0.01% | 385 |
|